A commitment to transparency, which was on display at the Sports Nutrition Summit this week in San Diego, is what drives NutraIngredients-USA’s coverage decisions.
The Chinese authorities have started a '100-day operation' in a bid to weed out unscrupulous industry practices prevalent in the country's health food market.
Ninety-eight per cent of the approved health food filings in China over the last 18 months went to domestic firms, a Chinese regulatory consultancy has found.
A patent infringement lawsuit making its way through the courts could have broad implications for the supplement industry, according to an attorney representing one of the parties.
Australian firm Bod Australia reported a record US$872,240 (A$1.22m) revenue for Q4 2018, due largely to portfolio expansion and new distribution agreements.
Almost 60% of complementary healthcare practitioners in Australia think recent reforms by the Therapeutic Good Administration (TGA) have had an adverse impact on the industry, according to the regulator's own stakeholder survey.
The Natural Products Association has objected to a proposal by the US Food and Drug Administration that NPA says will result in an expanded sharing of information on US firms with foreign governments. NPA said the proposal lacks transparency and runs...
A Red Bull cartoon advert has been banned for implying that the energy drink could increase focus and concentration in the workplace: claims that were not authorised on the EU Register.
The Food and Drug Administration has announced a regulatory framework for precertifying medical device software to streamline the way in which these devices are brought to market.
The industry can expect to see a boom in China's functional gummy market as the regulatory environment relaxes, according to Chinese supplement manufacturer Sirio Pharma.
Australian regulator the Therapeutic Goods Administration (TGA) is advising "extreme caution" when purchasing health supplements online, after discovering cancer-causing contaminants in a Chinese herbal cough product.
The supplement industry has an opportunity to make a powerful case about its self regulatory capabilities during the interregnum of federal regulatory authority imposed by the budget impasse.
